Ledger.Open graph →
SEC Form D · filed March 9, 2026

Solstice Oncology, Inc

Offering
$298.4M
Sold
$121.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Morgan Haller · Boston, MADirectorMaiken Keson-Brookes · Boston, MAExecCaroline Loew · Boston, MAExec · Director · PromoterDavid Feltquate · Boston, MAExecAndrew Levin · Boston, MADirectorJulie Grant · WATERTOWN, MADirectorEmily Minkow · Del Mar, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗